(Q48399058)

11 February 2018

title

The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure. (English)

1 reference

11 February 2018

main subject

heart failure

0 references

chronic heart failure

1 reference

Sato T

1

1 reference

11 February 2018

Yoshimura R

2

1 reference

11 February 2018

Kawada T

3

1 reference

11 February 2018

Shishido T

4

1 reference

11 February 2018

Miyano H

5

1 reference

11 February 2018

Sugimachi M

6

1 reference

11 February 2018

Sunagawa K

7

1 reference

11 February 2018

publication date

1 June 1998

1 reference

11 February 2018

Journal of Cardiac Failure

published in

1 reference

11 February 2018

volume

4

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

139-144

1 reference

11 February 2018

Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Functional and biochemical analysis of angiotensin II-forming pathways in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Regulatory role of brain angiotensins in the control of physiological and behavioral responses

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Angiotensin as neuromodulator/neurotransmitter in central control of body fluid and electrolyte homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

Blockade of angiotensin converting enzyme in circumventricular organs of the brain after oral lisinopril administration demonstrated by quantitative in vitro autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

The mysterious angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990255-X

7 January 2021

10.1016/S1071-9164(98)90255-X

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018